Open AccessEFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-COMPARATIVE CLINICAL TRIALS
Author(s) -
К. В. Жданов,
И. Г. Бакулин,
Д. А. Гусев,
В. Г. Морозов,
К. В. Козлов
Publication year - 2017
Publication title -
žurnal infektologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.185
H-Index - 5
eISSN - 2499-9865
pISSN - 2072-6732
DOI - 10.22625/2072-6732-2017-9-4-59-68
Subject(s) - ribavirin , medicine , adverse effect , pegylated interferon , hepatitis c , gastroenterology , clinical trial , combination therapy , hepatitis c virus , immunology , virus